At the same time Levemir provides significantly improved glycemic control and reduced rates of hypoglycemia.
Read More »Type 2 Diabetes Drives Inflammation Irrespective of BMI
Inflammation in patients with type 2 diabetes is independent of obesity, an observation that may partly explain the increased risk of cardiovascular disease among patients with diabetes.
Read More »Glycemic Control Reduces Risk of Strokes and Heart Attacks Dramatically
A retrospective analysis of 69,418 patients with diabetes showed that elevated A1C levels were statistically significantly associated with higher risk of macrovascular events.
Read More »Family Strategies for Raising a Healthy Child with Diabetes
Each and every day more kids are diagnosed with diabetes. It seems that the incidence of both Type 1 and Type 2 diabetes is growing at alarming rates. Laura Plunkett., BA Psychology, has made our jobs easier by writing The Challenge of Childhood Diabetes: Family Strategies for Raising a Healthy …
Read More »Keeping Your Mind Active
Researchers have concluded that your diet does play a role in preserving your mental function as you age, and so do health conditions. Dr. Sheri Colberg, author of The 7 Step Diabetes Fitness Plan: Living Well and Being Fit with Diabetes, has found that diabetes can also affect mental function. …
Read More »FDA Issues Warning For Byetta
There was a great deal of hubbub when the FDA asked Amylin Pharmaceuticals to notify prescribers about the small incidence of pancreatitis associated with Byetta®(exenatide). As usual the lay press and many medical papers went for sensationalism and overreacted. My intern Harine Sampaio, Doctor of Pharmacy Candidate, University of Florida …
Read More »Exubera Inhaled Insulin Is No Longer Available
Gone is the insulin bong as Pfizer announces they have spent 2.8 billion on the marketing and development of the first inhaled insulin, but have received just 12 million in sales in 2007. This will be a great opportunity to educate those patients using Exubera.
Read More »Reducing Glucose Can Extend Life by 25%
Life can be sweeter if you cut out the sugar, say German researchers
Read More »Lilly to Acquire Phase III Molecule Teplizumab for the Treatment of Type 1 Diabetes
Companies to Collaborate on the Development of Autoimmune Disease Treatments.
Read More »FDA Approves Supplemental New Drug Applications for Januvia (sitagliptin)
Merck & Co., announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA(TM) (sitagliptin), the only DPP-4 inhibitor available in the United States for the treatment of type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.